Inspire Medical Systems (Inspire Medical Systems) EPS (Diluted) : $-0.74 (TTM As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Inspire Medical Systems EPS (Diluted)?

Inspire Medical Systems's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was $0.49. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.74.

Inspire Medical Systems's EPS (Basic) for the three months ended in Dec. 2023 was $0.50. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.73.

Inspire Medical Systems's EPS without NRI for the three months ended in Dec. 2023 was $0.49. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.74.

During the past 3 years, the average EPS without NRIGrowth Rate was 31.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 9.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 9 years, Inspire Medical Systems's highest 3-Year average EPS without NRI Growth Rate was 31.00% per year. The lowest was -19.00% per year. And the median was 0.55% per year.

Inspire Medical Systems EPS (Diluted) Historical Data

The historical data trend for Inspire Medical Systems's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inspire Medical Systems EPS (Diluted) Chart

Inspire Medical Systems Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Diluted)

Get a 7-Day Free Trial

-1.40

-2.19

-1.54

-1.60

-0.72

Inspire Medical Systems Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EPS (Diluted)	Get a 7-Day Free Trial															0.10	-0.53	-0.41	-0.29	0.49

Competitive Comparison of Inspire Medical Systems's EPS (Diluted)

For the Medical Devices subindustry, Inspire Medical Systems's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Inspire Medical Systems's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Inspire Medical Systems's PE Ratio distribution charts can be found below:

* The bar in red indicates where Inspire Medical Systems's PE Ratio falls into.

Inspire Medical Systems EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Inspire Medical Systems's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-21.153	-	0)	/	29.302
	=	-0.72

Inspire Medical Systems's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(14.763	-	0)	/	29.520
	=	0.50

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.74

Inspire Medical Systems (NYSE:INSP) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Inspire Medical Systems EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Inspire Medical Systems's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Inspire Medical Systems (Inspire Medical Systems) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inspire Medical Systems Inc (NYSE:INSP) » Definitions » EPS (Diluted)

Comparable Companies

Traded in Other Exchanges

2DR:Germany 2DR:Germany

Address

5500 Wayzata Boulevard, Suite 1600, Golden Valley, MN, USA, 55416

Website

https://www.inspiresleep.com

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Executives

Timothy P. Herbert	director, 10 percent owner, officer: CEO and President	C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Jerry C Griffin	director	887L INDUSTRIAL ROAD, SAN CARLOS CA 94070
Carlton Weatherby	officer: Chief Strategy Officer	C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Steven Jandrich	officer: Chief Comp Off & VP, Human Res	C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Philip Ebeling	officer: Chief Operating Officer	INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BLVD., SUITE 1600, GOLDEN VALLEY MN 55416
John Rondoni	officer: Chief Technology Officer	C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Richard Buchholz	officer: Chief Financial Officer	C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Randy Ban	officer: Senior VP. & Sales & Marketing	C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Marilyn C Nelson	director	C/O EXXON MOBIL CORP, 5959 LAS COLINAS BLVD., IRVING TX 75039-2298
Cynthia Burks	director	C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Charisse Y Sparks	director	C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Georgia Melenikiotou	director	C/O INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BOULEVARD, SUITE 1600, GOLDEN VALLEY MN 55416
Bryan K Phillips	officer: See Remarks	9924 WEST 74TH STREET, EDEN PRAIRIE MN 55344
Shelley G. Broader	director	880 CARILLON PARKWAY, ST. PETERSBURG FL 33702
Casey M Tansey	director, 10 percent owner	2735 SAND HILL ROAD, MENLO PARK CA 94025